Last viewed: BIIB

Prices are updated after-hours

BIIB Nasdaq

Biogen Inc.

BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

(0.0% 1d) (-10.8% 1m) (-31.6% 1y) (0.0% 2d) (-0.5% 3d) (-0.6% 7d) (30.56% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 28,080,798,958
http://www.biogen.com
Sec Filling | Patents | 7400 employees

(US) Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

sclerosis neurodegenerative multiple sclerosis neurological treatment

Drugs

ALPROLIX (Coagulation Factor IX (Recombinant), Fc Fusion Protein)
AVONEX (interferon beta-1a)
Plegridy (peginterferon beta-1a)
Plegridy Pen (peginterferon beta-1a)
Spinraza (Nusinersen)
Tecfidera (dimethyl fumarate)
TECFIDERA (dimethyl fumarate)
TYSABRI (natalizumab)
Vumerity (diroximel fumarate)

add to watch list Paper trade email alert is off

Press-releases

EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Published: 2024-04-12 (Crawled : 12:00) - prnewswire.com
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -4.44% | O: 1.03% H: 0.49% C: -2.96%
neurology meeting

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
AVTX | $13.0 6.47% 4.76% 71K

|

| -33.09% | O: -22.8% H: 15.52% C: 1.07%
ICLR | News | $306.45 2.86% 2.68% 860K

|

Health Technology

| -9.15% | O: -2.95% H: 0.0% C: -1.43%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -10.35% | O: -1.11% H: 0.16% C: -2.56%
biotech leaders therapeutics

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published: 2024-03-31 (Crawled : 00:00) - prnewswire.com
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -11.14% | O: -0.88% H: 0.0% C: 0.0%
leqembi fda disease license treatment alzheimer's application submission

Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480

|

Health Technology

| 0.56% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $47.69 1.15% 1.13% 1.6M

|

Health Technology

| -2.1% | O: 0.42% H: 0.0% C: 0.0%
DYN | $25.44 2.29% 2.24% 810K

|

Health Technology

| -9.92% | O: -13.24% H: 11.02% C: 6.37%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -11.43% | O: -0.15% H: 0.23% C: -0.5%
ceo therapeutics

Pilates Equipment Market size to grow by USD 101.05 million from 2022 to 2027, North America to account for 37% of the growth, Technavio
Published: 2024-03-19 (Crawled : 21:00) - prnewswire.com
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -11.64% | O: -0.66% H: 1.0% C: 0.45%
america million market

Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480

|

Health Technology

| -0.67% | O: -0.02% H: 0.0% C: 0.0%
BAX | $41.02 1.54% 0.8% 2.6M

|

Health Technology

| -1.25% | O: 0.02% H: 1.03% C: 0.96%
SNY | News | $47.69 1.15% 1.13% 1.6M

|

Health Technology

| -2.02% | O: -1.51% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 3.6M

|

Health Technology

| -8.5% | O: 0.11% H: 0.59% C: 0.1%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -11.95% | O: -0.48% H: 0.31% C: 0.13%
reach cancer treatment global market

World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New Opportunities - Outcome Potential, Technology Environment, Target Solutions
Published: 2024-03-16 (Crawled : 04:20) - prnewswire.com
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| Email alert Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.6M

|

Health Technology

| Email alert Add to watchlist
JNJ | News | $149.56 0.3% -0.17% 6.9M

|

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 1.67% -2.18% 480

|

Health Technology

| Email alert Add to watchlist
world cancer research solutions immunotherapy technology market

Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $2.16 6.93% 6.05% 190K

|

| 24.86% | O: 1.73% H: 1.7% C: -7.39%
SNY | News | $47.69 1.15% 1.13% 1.6M

|

Health Technology

| -2.64% | O: 0.01% H: 0.0% C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M

|

Health Technology

| -25.73% | O: -0.6% H: 0.74% C: -3.66%
BCLI A | $0.525 -2.8% -1.71% 160K

|

Health Technology

| 61.09% | O: -2.43% H: 2.8% C: -4.02%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -16.03% | O: -0.32% H: 0.18% C: -0.86%
expected sclerosis treatment growth market

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ABCL | $3.97 -1.0% -0.63% 1.6M

|

| -16.77% | O: 5.03% H: 0.0% C: 0.0%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -13.47% | O: 0.03% H: 3.1% C: 3.03%
neurological

New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
IONS | $41.84 1.88% 1.86% 630K

|

Health Technology

| -5.32% | O: 0.05% H: 1.32% C: 0.18%
BIIB | $193.18 -0.48% -0.48% 1.2M

|

Health Technology

| -11.07% | O: 0.11% H: 1.16% C: 0.04%
spinraza biomarker potential therapy

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001127602-24-012414	4	2024-04-04	2024-04-02	Sell	S	93	4886
0001127602-24-012405	4	2024-04-04	2024-04-01	Sell	M	240	0
0001127602-24-012405	4	2024-04-04	2024-04-01	Sell	F	117	9634
0001127602-24-012405	4	2024-04-04	2024-04-01	Buy	M	240	9751
0001127602-24-006947	4	2024-02-27	2024-02-22	Sell	S	262	4886

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 26M

|

AGBA | $2.97 137.6% 57.48% 66M

|

EDBL | News | $6.59 75.27% 41.8% 2M

|

ZAPP | $4.44 50.2% 33.12% 370K

|

MTC | $2.24 43.59% 30.67% 6M

|

Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M

|

SHIM | $3.045 35.33% 26.23% 870K

|

HKIT | $1.33 30.39% 24.16% 390K

|

Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M

|

Wholesale Trade

OST | $0.5 25.0% 21.88% 280K

|

Last 48 Hours Insiders Buying

MEGI | $11.98 1.91% 0.0% 140K

|

| 00:30
CTRN P 29000 | $22.23 0.05% 0.13% 100K

|

| 22:00
CONN | $3.7 1.09% 1.35% 74K

|

| 21:30
TGEN P 6000 | $0.685 -0.68% 39.71% 6.6K

|

| 18:30
CMTV P 700 | $16.59 5.4% 17.43% 1K

|

Finance and Insurance

| 18:30
FNB | $13.63 2.17% 0.66% 2.5M

|

| 17:30
RMCF | $3.54 -0.84% 0.28% 2.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar